Ultrasound Biomicroscopic Assessment of Intraocular Lens Tilt and Decenteration After Phacoemulsification
1 other identifier
observational
100
1 country
1
Brief Summary
This study aims to assess intraocular lens (IOL) tilt and decenteration by means of ultrasound biomicroscopy after phacoemulsification.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Oct 2025
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2025
CompletedFirst Submitted
Initial submission to the registry
August 12, 2026
CompletedFirst Posted
Study publicly available on registry
August 18, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2026
CompletedAugust 18, 2026
August 1, 2026
1 year
August 12, 2026
August 12, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Measurement of intraocular lens tilt
Measurement of intraocular lens (IOL) tilt. The intraocular lens (IOL) position was measured as the Anterior Chamber Depth (ACD), defined as the distance between the anterior border of the hyperreflective line marking the central posterior corneal surface and the anterior IOL optic surface at the centre of the pupillary space.
Six months after surgery
Secondary Outcomes (1)
Measurement of intraocular lens decenteration
Six months after surgery
Study Arms (2)
Group 1
Patients with implanted hydrophilic intraocular lens (IOL).
Group 2
Patients with implanted hydrophobic intraocular lens (IOL).
Interventions
Scanning is conducted with the non-dilated eye in a central position and the patient in the supine position. A drop of a topical anesthetic agent (benoxinate hydrochloride) is applied to both eyes.
Eligibility Criteria
A prospective, observational, hospital-based study which will be conducted in the Department of Ophthalmology, Sohag University Hospital, Egypt.
You may qualify if:
- Both sexes.
- Patients with senile cataract prepared for phacoemulsification and IOL implantation.
You may not qualify if:
- Age \<45 years.
- Complicated ataract.
- Coexisting ocular disorders (Glaucoma, Pseudoexfoliation Syndrome, Sublaxation, Chronic Iridocyclitis).
- Previous ocular surgery.
- Complicated phacoemulsification.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Sohag Universitylead
Study Sites (1)
Sohag University
Sohag, Sohag Governorate, 82511, Egypt
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Resident of Ophthalmology, Faculty of Medicine, Sohag University, Egypt
Study Record Dates
First Submitted
August 12, 2026
First Posted
August 18, 2026
Study Start
October 1, 2025
Primary Completion
October 1, 2026
Study Completion
October 1, 2026
Last Updated
August 18, 2026
Record last verified: 2026-08
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL
- Time Frame
- After the end of study for one year.
- Access Criteria
- The data will be available upon a reasonable request from the corresponding author.
The data will be available upon a reasonable request from the corresponding author after the end of study for one year.